O-Charoenrat P - Search Results

1

Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.

Oo KK, Kamolhan T, Soni A, Thongchot S, Mitrpant C, O-Charoenrat P, Thuwajit C, Thuwajit P. Oo KK, et al. Among authors: o charoenrat p. BMC Cancer. 2021 Jan 14;21(1):65. doi: 10.1186/s12885-020-07761-w. BMC Cancer. 2021. PMID: 33446140 Free PMC article.

2

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.

Amornsupak K, Insawang T, Thuwajit P, O-Charoenrat P, Eccles SA, Thuwajit C. Amornsupak K, et al. BMC Cancer. 2014 Dec 15;14:955. doi: 10.1186/1471-2407-14-955. BMC Cancer. 2014. PMID: 25512109 Free PMC article.

3

High ASMA⁺ Fibroblasts and Low Cytoplasmic HMGB1⁺ Breast Cancer Cells Predict Poor Prognosis.

Amornsupak K, Jamjuntra P, Warnnissorn M, O-Charoenrat P, Sa-Nguanraksa D, Thuwajit P, Eccles SA, Thuwajit C. Amornsupak K, et al. Clin Breast Cancer. 2017 Oct;17(6):441-452.e2. doi: 10.1016/j.clbc.2017.04.007. Epub 2017 Apr 21. Clin Breast Cancer. 2017. PMID: 28533055 Free article.

4

Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells.

Sumransub N, Jirapongwattana N, Jamjuntra P, Thongchot S, Chieochansin T, Yenchitsomanus PT, Thuwajit P, Warnnissorn M, O-Charoenrat P, Thuwajit C. Sumransub N, et al. Oncol Lett. 2020 Mar;19(3):2422-2430. doi: 10.3892/ol.2020.11338. Epub 2020 Jan 23. Oncol Lett. 2020. PMID: 32194742 Free PMC article.

5

Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines.

Thongchot S, Jamjuntra P, Prasopsiri J, Thuwajit P, Sawasdee N, Poungvarin N, Warnnissorn M, Sa-Nguanraksa D, O-Charoenrat P, Yenchitsomanus PT, Thuwajit C. Thongchot S, et al. Among authors: o charoenrat p. Oncol Rep. 2021 Dec;46(6):254. doi: 10.3892/or.2021.8205. Epub 2021 Oct 15. Oncol Rep. 2021. PMID: 34651665 Free PMC article.

6

The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome.

Sa-Nguanraksa D, Thasripoo C, Samarnthai N, Kummalue T, Thumrongtaradol T, O-Charoenrat P. Sa-Nguanraksa D, et al. Among authors: o charoenrat p. Transl Cancer Res. 2020 Oct;9(10):6344-6353. doi: 10.21037/tcr-20-1120. Transl Cancer Res. 2020. PMID: 35117242 Free PMC article.

7

Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer.

Thongchot S, Jirapongwattana N, Luangwattananun P, Chiraphapphaiboon W, Chuangchot N, Sa-Nguanraksa D, O-Charoenrat P, Thuwajit P, Yenchitsomanus PT, Thuwajit C. Thongchot S, et al. Among authors: o charoenrat p. Mol Cancer Ther. 2022 May 4;21(5):727-739. doi: 10.1158/1535-7163.MCT-21-0823. Mol Cancer Ther. 2022. PMID: 35313339 Free PMC article.

8

Anti-PD-L1 × anti-CD3 bispecific T-cell engager-armed T cells can overcome immunosuppression and redirect T cells to kill breast cancer cells expressing PD-L1.

Luangwattananun P, Sangsuwannukul T, Supimon K, Thuwajit C, Chieochansin T, Sa-Nguanraksa D, Samarnthai N, O-Charoenrat P, Junking M, Yenchitsomanus PT. Luangwattananun P, et al. Among authors: o charoenrat p. Int Immunopharmacol. 2023 Nov;124(Pt B):111012. doi: 10.1016/j.intimp.2023.111012. Epub 2023 Oct 5. Int Immunopharmacol. 2023. PMID: 37804657

9

Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells.

Thongchot S, Aksonnam K, Prasopsiri J, Warnnissorn M, Sa-Nguanraksa D, O-Charoenrat P, Thuwajit P, Yenchitsomanus PT, Thuwajit C. Thongchot S, et al. Among authors: o charoenrat p. BMC Med. 2024 Sep 18;22(1):400. doi: 10.1186/s12916-024-03625-3. BMC Med. 2024. PMID: 39294656 Free PMC article.

10

A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops.

O-Charoenrat P, Rhys-Evans P, Eccles S. O-Charoenrat P, et al. Int J Cancer. 2002 Aug 10;100(5):527-33. doi: 10.1002/ijc.10531. Int J Cancer. 2002. PMID: 12124801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters